JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 59 filers reported holding JANUX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,991 | -45.4% | 4,265 | -35.7% | 0.00% | – |
| Q2 2023 | $78,734 | +110.9% | 6,633 | +115.0% | 0.00% | – |
| Q1 2023 | $37,328 | +3632.8% | 3,085 | +6755.6% | 0.00% | – |
| Q3 2022 | $1,000 | -99.7% | 45 | -99.8% | 0.00% | – |
| Q2 2022 | $362,000 | +432.4% | 29,640 | +525.1% | 0.00% | – |
| Q1 2022 | $68,000 | -58.3% | 4,742 | -42.3% | 0.00% | – |
| Q4 2021 | $163,000 | +8050.0% | 8,223 | +11012.2% | 0.00% | – |
| Q3 2021 | $2,000 | – | 74 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $105,869,000 | 2.82% |
| 5AM Venture Management, LLC | 446,266 | $5,449,000 | 1.35% |
| Samsara BioCapital, LLC | 360,414 | $4,401,000 | 1.17% |
| BVF INC/IL | 1,470,334 | $17,953,000 | 0.87% |
| Orbimed Advisors | 2,836,386 | $34,632,000 | 0.63% |
| EcoR1 Capital, LLC | 1,421,319 | $17,354,000 | 0.60% |
| Parkwood LLC | 33,750 | $412,000 | 0.07% |
| Woodline Partners LP | 286,383 | $3,497,000 | 0.05% |
| Cerity Partners LLC | 150,933 | $1,843,000 | 0.02% |
| JANUS HENDERSON GROUP PLC | 2,127,797 | $25,966,000 | 0.02% |